Nuclear Medicine: Page 349

Radiopharma firms broaden horizons with new agents

By Brian Casey

November 8, 2006

SNM offers travel tips for nuke med patients

By AuntMinnie.com staff writers

SNM is advising medical professionals to counsel patients who undergo nuclear medicine procedures that residual radiation from medical treatments may cause travel delays due to increased security scanning at places such as airport boarding areas, rail stations, ports, international border crossings, bridges, and tunnels.

November 8, 2006

IBA Molecular begins distribution from Kansas City

By AuntMinnie.com staff writers

IBA Molecular has commenced distribution of PET radiopharmaceuticals from a site in Kansas City, MO.

November 8, 2006

New growth for diagnostic radiopharmaceuticals

By Marvin Burns

Based on the number of new products in the pipeline and the amount of venture capital being invested, the future looks promising for radiopharmaceuticals. Current research efforts include novel approaches to imaging myocardial infarction, congestive heart failure, in vivo infection imaging, and new molecular imaging methodologies for oncology.

November 8, 2006

Dilon Technologies

By Kate Madden Yee

Gamma camera developer Dilon Technologies of Newport News, VA, will introduce a work-in-progress retrofit for its dedicated scintimammography system, Dilon 6800 Gamma Camera.

November 8, 2006

Eckert & Ziegler show Q3 uptick

By AuntMinnie.com staff writers

Radioisotope and radiopharmaceutical developer Eckert & Ziegler Strahlen-und Medizintechnik of Berlin reported record revenues for the company's fiscal 2006 third quarter (end-September 30).

November 7, 2006

Draxis Health notches Q3 revenue and profit gains

By AuntMinnie.com staff writers

Double-digit advances in its contract manufacturing and radiopharmaceuticals segments fueled revenue and earnings growth for Canadian pharmaceutical firm Draxis Health in the third quarter (end-September 30).

November 1, 2006

Digirad shows Q3 revenue slump

By AuntMinnie.com staff writers

Nuclear medicine vendor Digirad reported a fiscal 2006 third-quarter downturn in consolidated revenues, but said that it continued to make progress in trimming its net losses.

October 30, 2006

Study backs dual modality of microSPECT/CT

By AuntMinnie.com staff writers

Mayo Clinic researchers say the combined technologies of microSPECT and microCT imaging can accurately quantify intratumoral radioisotope uptake in vivo, and the hybrid technique is more reliable than planar or microSPECT imaging alone.

October 25, 2006

Scintigraphy pegs potential responders to plantar fasciitis treatment

By Shalmali Pal

Plantar fasciitis is the most common cause of heel pain but the differential diagnosis can include Achilles tendinitis, retrocalcaneal bursitis, and calcaneum fracture. Bone scintigraphy is often used to identify the source of heel pain, and the modality may play a predictive role in treatment as well, according to a new study by researchers from Australia and the U.K.

October 24, 2006

Schaumburg promoted to top post at UltraSPECT

Nuclear medicine firm UltraSPECT has promoted John Schaumburg to the post of president.

October 23, 2006

Instrumentation, attenuation correction steer nuclear cardiology's future

By Eric Barnes

Nuclear cardiology modalities are seeing a resurgence of late, which is not to say the most widespread heart-imaging modalities were in decline. Still, recent technical improvements on multiple fronts, from detector technology to hybrid modalities like SPECT/CT and PET/CT, seem to have sharpened the modalities' future prospects as they have sharpened the images themselves.

October 22, 2006

Previous Page

Page 349 of 440

Next Page